Aoyuan Healthy Life Group (3662) fair value: what the stock is really worth
As of Sep 30, 2026: fair value of Aoyuan Healthy Life Group HK$0.94, price HK$0.38, upside +150.1%, quality 54 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Aoyuan Healthy Life Group for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 29, 2026.
How to read this chart
60‑month range HK$0.2700 – HK$6.62 · fair‑value band HK$0.7390 – HK$1.15 · the HK$0.3750 price screens below the HK$0.9380 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 29, 2026.
Follow Aoyuan Healthy Life in your weekly email
Every Wednesday you see whether Aoyuan Healthy Life is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Starjoy Wellness and Travel Company Limited, through its subsidiaries, provides property management and commercial operational services in the People's Republic of China. The company operates through Property Management Services and Commercial Operational Services segments.
Show more
Starjoy Wellness and Travel Company Limited, through its subsidiaries, provides property management and commercial operational services in the People's Republic of China. The company operates through Property Management Services and Commercial Operational Services segments. It offers property management services for residential communities, commercial complexes, office buildings, villas, and tourist towns; and sales assistance services, community value-added services, and heating services for both residential and non-residential units to property developers, property owners, and residents. The company also provides commercial operation and management services and market positioning, and business tenant sourcing services to commercial property developers and commercial property lessees. In addition, it engages in the operation of the mobile application; provision of cleaning and gardening, design management and consulting, decoration and furniture, engineering consulting, and health management services. The company was formerly known as Aoyuan Healthy Life Group Company Limited and changed its name to Starjoy Wellness and Travel Company Limited in January 2024. The company was founded in 2000 and is based in Guangzhou, the People's Republic of China.
Stock analysis
Aoyuan Healthy Life Group (3662) currently trades at HK$0.3750, while our model-based Fair Value estimate is HK$0.9380, implying the stock looks roughly 60.0% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of HK$3.71 per share, and 16 of the 16 models we run sit above the HK$0.3750 price.
Bear case: the Dividend Discount group reads lowest at HK$0.4100, and 0 of the 16 models stay below the price. Evidence for this calculation is low.
Scenario range: HK$0.7390 (bear) to HK$1.15 (bull), the price of HK$0.3750 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 54/100 (solid quality), in the Real Estate sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Aoyuan Healthy Life Group reported revenue of 1.2B CNY in FY2025 versus 1.9B CNY in FY2021, a compound −11.0%/yr. Reported net income was 51.6M CNY in FY2025.
Key figures
Market cap HK$272M (≈ $34.7M) · P/E ratio 4.6 · P/S ratio 0.19 · EPS (TTM) HK$0.0300 · Dividend yield 7.1% · Net margin 4.2% · Return on equity 3.9% · Return on assets (EBIT) 4.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 21% below its 52-week high and 39% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Real Estate peers we cover trades at −10% fair-value upside, at 150%, 3662 screens cheaper than that median.
Fair Value models
Bear HK$0.7390Fair Value HK$0.9380Bull HK$1.15
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (HK$0.0225 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−10.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−9.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.8%
Start year 2020 (pandemic). Over 10 years: +21.1% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+21.1%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−17.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year−24.6%
Dividend (yield on the price)7.1%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−24.6% vs 3.9%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.22% → 8%
Start year 2020 (pandemic)
Growth Forecast
Little optimism in the price
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
less than -40 %
Yearly growth needed for the next five years to justify today's price.
Compare Aoyuan Healthy Life Group with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Real Estate Services · 539 stocks
Beats the industry median on 9/12 measures
Overall it ranks above its industry peers.
Valuation
Quality Score56 · Above median
Fair Value upside+150.1% · Top 25%
Profitability
Return on equity (TTM)3.9% · Above median
Return on assets2.7% · Above median
Net margin (TTM)4.2% · Below median
Operating margin (TTM)7.7% · Below median
Growth and dividend
Revenue growth−7.1% · Below median
Dividend yield (TTM)7.1% · Top 25%
Valuation Multiplesvs Real Estate Services median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Aoyuan Healthy Life Group Fair Value". https://www.fairvalue-calculator.com/stock/3662
Frequently asked questions
Is Aoyuan Healthy Life Group (3662) overvalued or undervalued?
As of Sep 29, 2026, our model estimates a fair value of HK$0.9380 versus a price of HK$0.3750, about +150% upside (undervalued).
What is the fair value of 3662?
Our model-based fair value for Aoyuan Healthy Life Group is HK$0.9380 (as of Sep 29, 2026), built from audited fundamentals. The current price: HK$0.3750.
What is the quality score of 3662?
Aoyuan Healthy Life Group has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Aoyuan Healthy Life Group (3662)?
Our model-based price target is the fair value of HK$0.9380 (as of Sep 29, 2026) from 16 valuation models. Cautious scenario HK$0.7390, optimistic scenario HK$1.15. It is a calculation from audited fundamentals, not an analyst target.
What is the Aoyuan Healthy Life Group stock forecast for 2026?
Our models put fair value at HK$0.9380, about +150% upside versus a price of HK$0.3750 (undervalued). Cautious scenario HK$0.7390, optimistic scenario HK$1.15. The calculation is refreshed regularly with new filings.
What is the revenue of Aoyuan Healthy Life Group (3662)?
Aoyuan Healthy Life Group reported trailing-twelve-month revenue of about 1.2B CNY (latest available figure, as of Sep 29, 2026).
Does Aoyuan Healthy Life Group pay a dividend?
Aoyuan Healthy Life Group currently shows a dividend yield of about 7.07% relative to its recent price (as of Sep 29, 2026).
What growth is priced into Aoyuan Healthy Life Group (3662)?
For today's price to be fair in a discounted-cash-flow model, Aoyuan Healthy Life Group would have to grow free cash flow by less than minus 40 % per year for five years (discount rate 9.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -2.8 % per year. As of Sep 29, 2026.
What discount rate (WACC) does the fair value of 3662 use?
Our models discount Aoyuan Healthy Life Group at 9.5 %: a base by market capitalisation (nano), damped by beta 0.71, country premium for Hong Kong. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Aoyuan Healthy Life Group that is less than minus 40 % per year a year over ten years, using the same discount rate (9.5 %) and the same formula as our fair value.
How much growth has Aoyuan Healthy Life Group (3662) delivered so far?
Over the past 5 years revenue at Aoyuan Healthy Life Group grew -2.8 % a year. The price currently implies less than minus 40 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Aoyuan Healthy Life Group (3662) growing?
The median revenue growth in the sector is +1.9 % a year. That is the yardstick for the growth priced into Aoyuan Healthy Life Group (less than minus 40 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Aoyuan Healthy Life Group (3662)?
The free-cash-flow yield on the price is 13.58 %: that much free cash flow Aoyuan Healthy Life Group produces per unit of market value. When it exceeds the discount rate of our models (9.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Aoyuan Healthy Life Group (3662)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Aoyuan Healthy Life Group it is HK$0.9380 per share (as of Sep 29, 2026), against a price of HK$0.3750. It is the blended result of 16 valuation models (cash flow, earnings, asset, dividend).
Is Aoyuan Healthy Life Group stock overvalued or undervalued in 2026?
As of Sep 29, 2026, 3662 trades below its calculated fair value: price HK$0.3750, fair value HK$0.9380, a gap of about +150% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 3662?
No. The price is what the market pays today (HK$0.3750); the fair value is what the company's own numbers justify (HK$0.9380). For Aoyuan Healthy Life Group the two are HK$0.5630 per share apart. That gap is exactly why we show both numbers side by side.
How much is Aoyuan Healthy Life Group worth?
The market values Aoyuan Healthy Life Group at about HK$272M (market capitalisation, as of Sep 29, 2026). Per share that is HK$0.3750; our models calculate a fair value of HK$0.9380 per share.
What do the bullish and bearish scenarios say about 3662?
Our models span a range for Aoyuan Healthy Life Group: cautious scenario HK$0.7390, base HK$0.9380, optimistic HK$1.15 per share (as of Sep 29, 2026, price HK$0.3750). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 3662?
Aoyuan Healthy Life Group trades at a price-to-earnings ratio of 4.6 (as of Sep 29, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of HK$0.9380 is built from several models across several years. Other multiples: P/B 0.2, P/S 0.2.
How solid is the balance sheet of Aoyuan Healthy Life Group (3662)?
Balance-sheet figures for Aoyuan Healthy Life Group (as of Sep 29, 2026): return on equity 3.9%. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is 3662 from its 52-week high?
Aoyuan Healthy Life Group trades at HK$0.3750, about 21% below its 52-week high of HK$0.4750 and 39% above the low of HK$0.2700 (as of Sep 30, 2026). Distance from the high says nothing about value: that is what the fair value of HK$0.9380 is for.
Which stocks are comparable to Aoyuan Healthy Life Group?
From the same area (Real Estate) we also value CBRE Group, KE Holdings, Cellnex Telecom, S.A, Swire Properties Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Aoyuan Healthy Life Group stock attractive at the current price?
The data as of Sep 29, 2026: price HK$0.3750, calculated fair value HK$0.9380 (+150%), Quality Score 54/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 3662 calculated?
We run Aoyuan Healthy Life Group through 16 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of HK$0.9380, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.7 % above its aggregate fair value. Aoyuan Healthy Life Group currently trades 60 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Aoyuan Healthy Life Group (3662)?
The closing price on Sep 30, 2026 was HK$0.3750. Our model-based fair value is HK$0.9380, about +150% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Aoyuan Healthy Life Group right now?
The price is below even our cautious bear case (HK$0.7390). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (54/100) at a price below fair value, the discount is the argument here, not the business quality. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Where does the earnings growth of Aoyuan Healthy Life Group (3662) come from?
Earnings per share at Aoyuan Healthy Life Group grew +13.3 % a year from 2015 to 2025. Broken into its drivers: revenue per share +23.4 %, EBIT margin −8.7 %, tax rate +1.0 %, residual (interest, one-offs) −0.5 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Aoyuan Healthy Life Group
How large is the market capitalisation of Aoyuan Healthy Life Group (3662)?
The market capitalisation of Aoyuan Healthy Life Group is HK$272M (≈ $34.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Aoyuan Healthy Life Group (3662)?
The price-to-sales ratio of Aoyuan Healthy Life Group is 0.19 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Aoyuan Healthy Life Group (3662)?
Earnings per share at Aoyuan Healthy Life Group are HK$0.0300 (price ÷ EPS = P/E 4.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Aoyuan Healthy Life Group (3662)?
The dividend yield of Aoyuan Healthy Life Group is 7.1% (payout 88.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Aoyuan Healthy Life Group (3662)?
The net margin of Aoyuan Healthy Life Group is 4.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Aoyuan Healthy Life Group (3662)?
The return on equity (ROE) of Aoyuan Healthy Life Group is 3.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Aoyuan Healthy Life Group (3662)?
On an EBIT basis the return on assets of Aoyuan Healthy Life Group is 4.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Aoyuan Healthy Life Group (3662)?
The operating margin of Aoyuan Healthy Life Group is 7.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Aoyuan Healthy Life Group (3662)?
Revenue at Aoyuan Healthy Life Group is growing −7.1% versus a year earlier (3y avg −9.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Aoyuan Healthy Life Group (3662)?
Earnings per share at Aoyuan Healthy Life Group are growing +82.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Aoyuan Healthy Life Group (3662) hold?
Aoyuan Healthy Life Group holds more cash than debt, 942M CNY net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Aoyuan Healthy Life Group in the live analysis
One click puts Aoyuan Healthy Life Group on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
